HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The efficacy of interferon-alpha in a patient with resistant familial Mediterranean fever complicated by polyarteritis nodosa.

Abstract
Familial Mediterranean fever (FMF) is a recurrent self-limiting polyserositis. Polyarteritis nodosa (PAN) complicating FMF is very rare. Here, we present a 17-year-old male patient with FMF who subsequently developed PAN 2 weeks after hepatitis A infection. This case was also complicated with perirenal haematoma, and right nephrectomy was performed. The clinical condition of the patient was improved after therapy with intravenous and oral corticosteroid and intravenous cyclophosphamide. However, the FMF attacks and vasculitic skin lesions again occurred while he was using colchicine plus immunosuppressive agents a few months later. Interferon-alpha therapy was administered and the attacks were resolved within 3 months. He has not experienced any other symptom during the follow-up period of 28 months.
AuthorsMeral Calguneri, Sule Apras, Zeynep Ozbalkan, M Akif Ozturk
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 43 Issue 7 Pg. 612-4 (Jul 2004) ISSN: 0918-2918 [Print] Japan
PMID15335192 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Interferon-alpha
  • Colchicine
Topics
  • Adolescent
  • Angiography
  • Colchicine (therapeutic use)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Familial Mediterranean Fever (complications, diagnosis, drug therapy)
  • Follow-Up Studies
  • Humans
  • Interferon-alpha (administration & dosage)
  • Male
  • Polyarteritis Nodosa (complications, diagnostic imaging, drug therapy)
  • Risk Assessment
  • Severity of Illness Index
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: